Usually lag time on commercial availability....remembered back when adapalene took like forever to hit store shelves...like a good 8 months or so
From Lexicomp:
"Voltaren Arthritis Pain OTC 1% Gel: FDA approved February 2020; availability anticipated in Spring 2020."
(Olopatadine page not updated yet)
Yeah, I do also like buying newly OTC status drugs mainly for the experience/knowing the ins-outs of a product to make better recommendations. Changes the when to refer scenario as well
I do not think olopatadine will have much of a significant impact/not a game changer due to ketotifen fumarate already being out, other than some 3rd parties no longer wanting to cover Rx olopatadine (kind of like xyzal/levocetirizine a few years ago)